FDA Inspection
Symbiosis (Biopharm GmbH)Symbiosis (Biopharm GmbH) – FDA Inspection, Apr 29, 2021
Record Details
This FDA Inspection record concerns Symbiosis (Biopharm GmbH), with an inspection on April 29, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Symbiosis (Biopharm GmbH)
- Inspection Date
- April 29, 2021
- Product Type
- Drugs
View Company Profile
ID · 4c755587-42ea-4e36-a423-1ce84774d65b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1166201
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Symbiosis (Biopharm GmbH)
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Symbiosis (Biopharm GmbH)
- FDA Inspection 831533 - 2013-04-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.